EuroBioBank: Difference between revisions
CSV import |
CSV import |
||
| Line 25: | Line 25: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
Revision as of 16:52, 10 February 2025
EuroBioBank is a network of biobanks that was established in 2001 to facilitate the collection, storage, and distribution of biological samples. These samples are used for research into rare diseases, with a particular focus on neuromuscular disorders. The network is composed of 28 biobanks from 12 European countries, and it provides over 750,000 biological samples.
History
The EuroBioBank network was established in 2001 as part of the European Union's Rare Disease initiative. The goal was to create a centralized resource for researchers studying rare diseases, particularly neuromuscular disorders. The network has since grown to include 28 biobanks from 12 European countries.
Function
EuroBioBank's primary function is to collect, store, and distribute biological samples for research purposes. These samples include DNA, tissue samples, and cell lines. The network also provides data related to the samples, such as clinical and genetic information.
The network plays a crucial role in facilitating research into rare diseases. By providing a centralized resource for biological samples, EuroBioBank enables researchers to access the materials they need for their studies. This is particularly important for research into rare diseases, which often face challenges in obtaining sufficient samples for research due to the low prevalence of these conditions.
Structure
The EuroBioBank network is composed of 28 biobanks from 12 European countries. Each biobank operates independently, but they all adhere to the same standards and protocols for the collection, storage, and distribution of samples. This ensures consistency and quality across the network.
Impact
Since its establishment, EuroBioBank has facilitated numerous research projects into rare diseases. The network has provided over 750,000 biological samples, which have been used in a variety of studies. These include research into the genetic basis of neuromuscular disorders, the development of new diagnostic tests, and the evaluation of potential treatments.
